Conestoga Small Cap Fund Investors Class (CCASX)

56.20
Net Asset Value
-0.12%
1 Day
+14.81%
Year-to-Date
Overall Morningstar Rating
Small growth
Style or Category
No Load
Sales Expenses
1.54%
Expense Ratio
Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term growth of capital. Under normal market circumstances- the fund invests at least 80% of its net assets in equity securities of small-cap companies. Equity securities include American depositary receipts ("ADRs")- convertible securities- foreign and domestic common and preferred stocks- rights and warrants.

Performance

1 month+6.08% 3 years+18.17%
3 months+11.40% 5 years+16.58%
1 year+30.78% Since inception+12.59%
Data through --

Peer Comparisonvs. Small growth

 CCASXCategory
Performance 5-yr return+16.58%+11.88%
Expense ratio1.54%1.26%
Risk 5 year sharpe ratio1.010.90
Net assets$2.1B$1.1B
Average market cap$2.1B$3.7B
Average P/E36.426.5
Portfolio turnover24%24%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyConestoga Capital Advisors
Fund manager & tenureRobert Mitchell / 15 Years
Minimal initial investment$2,500.00
Minimum IRA investment--

Holdings

U.S. stock92.91%
Cash4.05%
International stock3.04%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Business service 19.67%
Healthcare 12.89%
Hardware 12.07%
Industrial materials 10.80%
Energy 8.99%
Top 10 Holdings
Portfolio weighting
NEOG Neogen Corp3.52%
MGPI MGP Ingredients Inc3.06%
EXPO Exponent Inc3.04%
-- 3.04%
EPAY Bottomline Technologies (DE) Inc2.81%
LGND Ligand Pharmaceuticals Inc2.78%
SSD Simpson Manufacturing Co Inc2.74%
OMCL Omnicell Inc2.71%
CMD Cantel Medical Corp2.70%
BLKB Blackbaud Inc2.68%